Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 5 Demographic and laboratory characteristics of patients according to ADMA tertile

From: Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function

  First tertile
(0.12 - 0.54) (N = 199)
Second tertile
(0.55 - 0.79) (N = 206)
Third tertile
(0.80 - 4.91) (N = 207)
P
Age (years) 62.37 ± 10.53 66.01 ± 11.95 65.64 ± 11.70 0.000**
Dialysis vintage (months) 2.48 ± 24.24 7.90 ± 1.48c 25.62 ± 1.92a,b 0.000**
Male 25 (21.6 %) 91 (78.4 %) 37 (19.7 %) 0.508***
Caucasian 31 (22.8 %) 105 (72.2 %) 51 (20.6 %) 0.440***
BMI (kg/cm2) 29.74 ± 5.55 29.11 ± 5.24 27.63 ± 13.43 0.000**
Waist circumference (cm) 99.46 ± 13.43 101.45 ± 11.40 101.88 ± 14.62 0.798*
Diabetes mellitus 15 (23.1 %) 50 (76.9 %) 32 (18.8 %) 0.895***
Metabolic syndrome 28 (19.4 %) 116 (80.6 %) 48 (17.8 %) 0.733***
Cardiovascular disease 66 (30.1 %) 77 (35.2 %) 76(34.7 %) 0.646***
o Cerebrovascular disease 0 (0.0 %) 20 (100.0 %) 13 (28.3 %) 0.073***
o Coronary disease 13 (29.5 %) 31 (70.5 %) 11 (16.9 %) 0.703***
o Peripheral vascular disease 22 (22.9 %) 35 (36.5 %) 39 (20.4 %) 0.697***
o Congestive heart failure 27 (34.2 %) 28 (35.4 %) 24 (30.4 %) 0.738***
Statin use 23 (21.9 %) 82 (78.1 %) 38 (19.4 %) 0.602***
Cholesterol(mM) 4.70 ± 1.08 4.45 ± 1.07c 4.59 ± 1.07a.b 0.000*
HDL-C(mM) 1.21 ± 0.34 1.05 ± 0.39 1.13 ± 0.36 a.b 0.000*
LDL-C(mM) 2,71 ± 0.92 2.53 ± 0.88 2.24 ± 2.24 a.b 0.000*
Triglycerides(mM) 1.99 ± 1.36 1.66 ± 1.14 1.84 ± 1.06 0.804**
Uric acid (mM) 0.36 ± 0.11 0.42 ± 0.12c 0.41 ± 0.10 b 0.000*
Creatinine(μM) 131.72 ± 81.33 845.10 ± 239.56c 947.65 ± 290.84a,b 0.000**
CRP (mg/dL) 0.50 ± 0.08 0.66 ± 0.21 0.50 ± 0.72 0.321**
  1. *ANOVA, **Kruskal-Wallis-one way- ANOVA, ***Pearson chi-square
  2. By post hoc Bonferroni test: a groups III and II, bgroups III and I, cgroups II and I